Caissa Capital Management ltd.

person

Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.

Political giving

—

Political receipts

—

Lobbying income

—

Lobbying expense

—

Federal awards

—

Relationships

Connected records

Relationship	Connected entity	Amount / weight	Period
insider of	Inc. Avalo Therapeutics	1,675,956.07	Apr 10, 2023 – Jun 26, 2023

Source coverage

sec insider: 0001929354

Caissa Capital Management ltd. — Influence Profile | Poliscope